Meta-Analysis of Randomized Controlled Trials Comparing Intracoronary and Intravenous Administration of Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes;Cutlip;Am J Cardiol,2001
2. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction;Martínez-Ríos;Am J Cardiol,2004
3. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials;De Luca;JAMA,2005
4. Comparison by meta-analysis of eptifibatide and tirofiban to abciximab in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention;Ottani;Am J Cardiol,2010
5. Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons;Mitchel;Circulation,1994
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis;Thrombosis Journal;2023-07-14
2. Antiplatelet Agents in Acute ST Elevation Myocardial Infarction;The American Journal of Medicine;2022-06
3. Bleeding with Tirofiban During Percutaneous Coronary Intervention;Pakistan Journal of Medical and Health Sciences;2021-10-30
4. Meta-Analysis of Randomized Controlled Trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention;The Anatolian Journal of Cardiology;2020
5. Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes;Medicine;2017-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3